The present application relates to the technical field of
inhalation anesthetic antagonism, and particularly relates to the application of a corticotropin-releasing
hormone receptor antagonist in the preparation of an
inhalation anesthetic antagonist. The present application first discovers that the corticotropin-releasing
hormone receptor of the dorsal raphe
nucleus is a key target of the action of an
inhalation anesthetic, and that the oculomotor nerve parvocellular
nucleus-dorsal raphe
nucleus neural loop mediates the effect of an inhalation anesthetic, and that a corticotropin-releasing
hormone receptor antagonist can block the excitatory effect of urocortin on the neurons of the dorsal raphe nucleus, thereby weakening the effect of an inhalation anesthetic. The present application first applies a corticotropin-releasing
hormone receptor antagonist in the preparation of an inhalation anesthetic antagonist, fills the technical gap in this field, is conducive to the rapid
postoperative recovery of patients under general
anesthesia, and has a broad application prospect.